Cronos (CRON) Depreciation & Amortization (CF) (2019 - 2026)

Cronos' (CRON) quarterly Depreciation & Amortization (CF) came in at $3.7 million in Q1 2026, up 31.23% year-on-year from $2.8 million in Q1 2025, and up 1.91% quarter-over-quarter from $3.7 million in Q4 2025.

Cronos (CRON) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Cronos' Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $3.7 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 31.23% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $15.1 million, a 44.74% increase from a year earlier, with the FY2025 full-year figure at $14.2 million, up 52.43% from the prior year.
  • Depreciation & Amortization (CF) rose to $3.7 million in Q1 2026 per CRON's latest filing, from $3.7 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $4.2 million in Q2 2022 and bottomed at $1.2 million in Q4 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $2.8 million (2022), against an average of $2.9 million.
  • Across the five-year window, Depreciation & Amortization (CF) plunged 59.59% in 2022 and jumped 177.73% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $2.6 million in 2022, then tumbled by 55.13% to $1.2 million in 2023, then surged by 114.53% to $2.5 million in 2024, then soared by 44.83% to $3.7 million in 2025, then increased by 1.91% to $3.7 million in 2026.
  • Per Business Quant, the three latest CRON Depreciation & Amortization (CF) figures stand at $3.7 million (Q1 2026), $3.7 million (Q4 2025), and $3.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn 3.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.73 Mn
Mar 31, 2026 3.73 Mn
Dec 31, 2025 3.66 Mn
Dec 31, 2025 3.66 Mn
Sep 30, 2025 3.53 Mn
Sep 30, 2025 3.53 Mn
Jun 30, 2025 4.20 Mn
Jun 30, 2025 4.20 Mn
Mar 31, 2025 2.84 Mn
Mar 31, 2025 2.84 Mn
Dec 31, 2024 2.53 Mn
Dec 31, 2024 2.53 Mn
Sep 30, 2024 3.57 Mn
Sep 30, 2024 3.57 Mn
Jun 30, 2024 1.51 Mn
Jun 30, 2024 1.51 Mn
Mar 31, 2024 1.73 Mn
Mar 31, 2024 1.73 Mn
Dec 31, 2023 1.18 Mn
Dec 31, 2023 1.18 Mn